Introduction
Silver sulfadiazine is a drug belongs to the sulfa drug antibiotics class [1] . It is mainly used to prevent and treat wound infections in burn patients by preventing the growth of infectious bacteria on the open wound [2] . It also helps in decreasing the risk of bacterial growth on the surrounding skin and blood and prevents the serious blood infection such as sepsis [3] . Silver sulfadiazine is a broad spectrum drug that mainly acts on the gram-negative bacteria. Moreover, it shows good tolerance and low toxicity in patients; thus, also used for third & fourth-degree burns [4] . The bactericidal activity of silver sulfadiazine is takes place on the cell membrane and cell wall of the bacteria. For this, the silver ions present in the drug, catalyse the disulphide bonds formation, which causes change in the protein structure and thereby inactivates the thiol-containing enzymes [5] . Also, the silver ions may act by intercalating the DNA that interferes with the process of replication and transcription of the bacteria [6] . The sulfadiazine part of drug acts by inhibiting the bacterial dihydropteroate synthase, thereby disrupting the folic acid metabolism and DNA synthesis in bacteria [7, 8] .
The silver sulfadiazine shows its effect by reacting at a slow and steady rate with serum and other body fluids, which allows only the slow and sustained delivery of silver ions into the wound area. However, it reduces the bioavailability of the drug within the body [9] . Also, the studies reported the poor solubility of the drug and its limited penetration through the intact skin [10] . Thus, the study of its physicochemical properties is done to improve its dissolution and absorption parameters in the formulation. The Biofield Energy Healing Treatment (the Trivedi Effect ® ) has been known for its considerable effect on the physicochemical and thermal behaviour of many compounds [11] [12] [13] [14] , that may also affect the solubility and bioavailability profile of both the pharmaceuticals and nutraceuticals.
A unique energy (infinite, para-dimensional electromagnetic field) is possessed by every living organism that surrounds their body and known as the "Biofield Energy". The Trivedi Effect ® is a phenomenon that is established as; a person can harness the inherently intelligent energy and transmit it anywhere on the planet through the possible mediation of neutrinos [15] . The National Institutes of Health/National Center for Complementary and Alternative Medicine (NIH/NCCAM) also recommended the Energy therapies and included them under the category of Complementary and Alternative Medicine (CAM) along with other therapies, medicines and practices such as naturopathy, homeopathy, traditional Chinese herbs and medicines, aromatherapy, Ayurvedic medicine, Qi Gong, Tai Chi, Reiki, hypnotherapy, yoga, chiropractic/osteopathic manipulation, meditation, massage, relaxation techniques, guided imagery, healing touch, acupuncture, acupressure, Rolfing structural integration, mindfulness, cranial sacral therapy and applied prayer [16] . Biofield (Putative Energy Fields) based Energy Healing Therapies have been known for their significant outcomes against various disease conditions with several advantages and therefore, accepted by most of the U.S. population [17] .
Besides, several studies reported the astounding capability of the Trivedi Effect ® -Consciousness Energy Healing Treatment for altering the characteristics of the non-living materials and living object(s), such as metals and ceramic [18, 19] , nutraceuticals/ pharmaceuticals [20] [21] [22] [23] , and organic compounds [24, 25] . It is also reported for its unique impact in the field of biotechnology [26] , microbiology [27] [28] [29] , skin health [30] , livestock [31] , and crops [32, 33] . Hence, in this study, the impact of the Trivedi Effect ® -Consciousness Energy Healing Treatment on silver sulfadiazine was evaluated with respect to the physicochemical and thermal properties by using the various analytical techniques such as, powder X-ray diffraction (PXRD), particle size analysis (PSA), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA)/differential thermogravimetric analysis (DTG).
Materials and Methods

Chemicals and Reagents
The silver sulfadiazine was purchased from Tokyo Chemical Industry Co., Ltd., Japan. All other chemicals used during the experiments were of analytical grade available in India.
Consciousness Energy Healing Treatment Strategies
The silver sulfadiazine test sample was divided into two parts. One part was considered as the control sample (no Biofield Energy Treatment was provided). Consequently, the second part of silver sulfadiazine was treated with the Trivedi Effect Further, the control sample was treated with a "sham" healer for comparison purposes. The "sham" healer did not have any knowledge about the Biofield Energy Treatment. After treatment, the Biofield Energy Treated and untreated sample were both kept in sealed conditions and characterized using PXRD, PSA, DSC, and TGA/DTG techniques.
Characterization Powder X-ray Diffraction (PXRD) Analysis
The PXRD analysis of silver sulfadiazine was performed with the help of RigakuMiniFlex-II Desktop X-ray diffractometer (Japan) [34, 35] . The Cu Kα radiation source tube output voltage used was 30 kV and tube output current 15 mA. Scans were performed at room temperature. The average size of individual crystallites was calculated from XRD data using the Scherrer's formula (1):
Where k is the equipment constant (0.94), G is the crystallite size in nm, λ is the radiation wavelength (0.154056 nm for Kα1 emission), β is the full-width at half maximum (FWHM), and θ is the Bragg angle [36] . The percent change in crystallite size (G) of silver sulfadiazine was calculated using the following equation 2:
Where G Control and G Treated are the crystallite size of the control and the Biofield Energy Treated samples, respectively.
Particle Size Analysis (PSA)
The particle size analysis of silver sulfadiazine was conducted on Malvern Mastersizer 2000, from the UK with a detection range between 0.01 µm to 3000 µm using wet method [37, 38] . The sample unit (Hydro MV) was filled with a dispersant medium (sunflower oil) and the stirrer operated at 2500 rpm. The PSA analysis of silver sulfadiazine was performed to obtain the average particle size distribution. Where, d (0.1) μm, d (0.5) μm, d (0.9) μm represent particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution. D (4,3) represents the average mass-volume diameter, and SSA is the specific surface area (m 2 /g). The calculations were done by using software Mastersizer Ver. 5.54. The percent change in particle size (d) at below 10% level (d 10 ), 50% level (d 50 ), 90% level (d 90 ), and D (4,3) was calculated using the following equation 3:
Where d Control and d Treated are the particle size (μm) for at below 10% level (d 10 ), 50% level (d 50 ), and 90% level (d 90 ) of the control and the Biofield Energy Treated samples, respectively.
The percent change in surface area (S) was calculated using the following equation 4:
Where S Control and S Treated are the surface area of the control and the Biofield Energy Treated silver sulfadiazine, respectively.
Differential Scanning Calorimetry (DSC)
The DSC analysis of silver sulfadiazine was performed with the help of DSC Q200, TA instruments. Sample of ~1-5 mg was loaded to the aluminium sample pan at a heating rate of 10 o C/ min from 30°C to 350°C [37, 38] . The % change in melting point (T) was calculated using the following equation 5:
Where T Control and T Treated are the melting point of the control and Biofield Energy Treated samples, respectively. The percent change in the latent heat of fusion (ΔH) was calculated using the following equation 6:
Where ΔH Control and ΔH Treated are the latent heat of fusion of the control and Biofield Energy Treated silver sulfadiazine, respectively.
Thermal
Gravimetric Analysis (TGA)/ Differential thermogravimetric analysis (DTG) TGA/DTG thermograms of silver sulfadiazine were obtained with the help of TGA Q50 TA instruments. Sample of 5 mg was loaded to the platinum crucible at a heating rate of 10 o C/min from 25°C to 1000°C with the recent literature [37, 38] . The % change in weight loss (W) was calculated using the following equation 7:
Where W Control and W Treated are the weight loss of the control and the Biofield Energy Treated silver sulfadiazine, respectively. The % change in maximum thermal degradation temperature (T max ) (M) was calculated using the following equation 8:
Where M Control and M Treated are the T max values of the control and the Biofield Energy Treated silver sulfadiazine, respectively.
Results and Discussion
Powder X-ray Diffraction (PXRD) Analysis
The diffractograms of the control and the Biofield Energy Treated sample showed peaks of high intensity and narrow base width that are the properties of crystalline materials (Figure 1) . However, the Bragg's angles of the characteristic peaks of the Biofield Energy Treated sample, including the highest intensity peak (2θ = 10.11°), were observed to differ from the Bragg's angles of the control sample (highest intensity peak at 2θ = 10.32°). It reveals some alterations in the crystalline structure of the Biofield Energy Treated sample after the Biofield energy Treatment. Moreover, the Biofield Energy Treated silver sulfadiazine also showed alterations in the intensities of the characteristic peaks and their corresponding crystallite sizes ranging from -75.25% to 31.21% and -8.80% to 192.76%, respectively (Table 1) . Besides, the huge alteration was observed in the average crystallite size of the Biofield Energy Treated sample (455.14 nm), which was significantly increased by 64.06% compared with the control sample (277.43 nm). In crystalline compounds, the changes in peak intensity corresponding to each diffraction face indicates the alteration in the crystal morphology [39] , and the alterations in the overall PXRD pattern are the proof of polymorphic transitions taking place in drug [40, 41] . Hence, such significant changes in the Bragg's angles of the peaks, their intensities, and the corresponding crystallite sizes indicate the altered morphology and polymorphic transitions of the Biofield Energy Treated silver sulfadiazine crystals after the Biofield Energy Treatment, compared with the untreated sample. Moreover, the variation in the polymorphic forms of pharmaceuticals is known for its impact on the drug performance in terms of its therapeutic efficacy, bioavailability, and toxicity [42, 43] . Thus, it could be presumed that the Trivedi Effect ® Treated sample might offer a better therapeutic response in comparison to the untreated silver sulfadiazine. The particle size distribution analysis of the control and the Biofield Energy Treated samples were done (Table 2) were reduced by 1.60%, 2.30%, 2.06%, and 4.40%, respectively compared to the control silver sulfadiazine. Therefore, the specific surface area (SSA) of the Biofield Energy Treated sample (0.551m 2 /g) was increased by 2.61% in comparison to the SSA of the control sample (0.537m 2 /g). Thus, it could be presumed the Biofield Energy Healing Treatment might reduce the particle size of silver sulfadiazine by acting as an external force [44] . The reduction in particle size is known to improve the solubility and absorption, and ultimately the bioavailability in the body by increasing the surface area of the drug [45] [46] [47] . Hence, the decreased particle size and increased surface area of the Biofield Energy Treated silver sulfadiazine after the Biofield Energy Treatment might be considered as the improved bioavailability profile of drug compared with the untreated sample. The DSC technique determines the enthalpy of the control and the Biofield Energy Treated samples, and thereby might show the glass transition temperature as well as the endothermic and exothermic events taken place during heating [48] . The DSC thermograms of the control and the Biofield Energy Treated sample showed the sharp endothermic peak at 261.85 and 262.04°C, respectively (Figure 2 ) that is considered as their melting points. It indicated the similar melting points of both the samples; however, the latent heat of fusion (∆H fusion ) of the Biofield Energy Treated sample (42.91 J/g) was significantly reduced by 21.52% (Table 3) compared with the control sample (54.68 J/g).
Particle Size Analysis (PSA)
Differential Scanning Calorimetry (DSC) Analysis
Moreover, there was an exothermic peak also observed in the thermograms of the control and the Biofield Energy Treated sample that is considered as the decomposition temperature. The analysis revealed that the decomposition temperature of the Biofield Energy Treated sample was decreased by 1.61%; whereas the ∆H decomposition was significantly increased by 32.03%, compared to the control sample (Table 3) . Hence, it could be assumed that the Biofield Energy Treatment might disrupt the molecular chains, as well as the crystal structure of the Biofield Energy Treated silver sulfadiazine that might be responsible for the alterations in the melting temperatures and latent heat [42] compared with the control sample.
Thermal Gravimetric Analysis (TGA)/ Differential Thermogravimetric Analysis (DTG) The TGA thermograms were used to establish the thermal degradation profile of the samples, displayed single step thermal degradation for the control and the Biofield Energy Treated samples (Figure 3) . The experimental data showed that the total weight loss due to thermal degradation of the Biofield Energy Treated sample was reduced by 1.86% in comparison to the control sample (Table 4) . In response to this, the residue amount of the Biofield Energy Treated sample was observed to be increased by 2.88% compared to the control sample. Thus, the thermal degradation of the Biofield Energy Treated sample was observed to be reduced after the Biofield Energy Treatment compared with the untreated silver sulfadiazine.
The first derivative of the weight loss curve (i.e., the DTG thermogram) is used to determine the temperature points at which the weight loss is most apparent [48] . In this study, the DTG thermograms of the control and the Biofield Energy Treated sample showed a single peak (Figure 4) . It was observed that the Biofield Energy Treated silver sulfadiazine showed maximum weight loss T max at 276.78°C, which was slightly increased by 0.94% (Table 4 ) in comparison to the T max of the control silver sulfadiazine (274.21°C). Overall, the TGA/DTG study indicated that the thermal stability of the Biofield Energy Treated sample was improved compared with the control sample. 
Conclusion
The impact of the Trivedi Effect ® -Consciousness Energy Healing Treatment on silver sulfadiazine was significant on the crystal morphology and structure, particle size, and thermal properties. The PXRD data showed alterations in the Bragg's angles of the characteristic peaks of the Biofield Energy Treated sample along with the peak intensity in comparison to the untreated sample. The intensities of those peaks of the Biofield Energy Treated sample were altered ranging from -75.25% to 31.21%; while the crystallite sizes showed the significant alteration ranging from -8.80% to 192.76%, compared with the control sample. Moreover, the Biofield Energy Treated sample showed a significant increase in the average crystallite size by 64.06% compared with the untreated silver sulfadiazine sample. The particle size distribution of the Biofield Energy Treated sample also indicated significant alterations in the particle sizes after the Biofield Energy Treatment. The particle size values were reduced by 1.60%, 2.30%, 2.06%, and 4.40% at d 10 , d 50 , d 90 , and  D (4,3) , respectively compared to the control sample. Therefore, the specific surface area of the Biofield Energy Treated sample was increased by 2.61% compared to the control sample. The ∆H fusion of the Biofield Energy Treated silver sulfadiazine was significantly decreased by 21.52% compared with the untreated sample. Nevertheless, the ∆H decomposition of the Biofield Energy Treated sample was significantly increased by 32.03% compared to the control sample. The total weight loss analyzed from the TGA analysis showed 1.86% reduction in the Biofield Energy Treated sample that resulted in 2.88% increase in the residual amount in comparison to the untreated silver sulfadiazine. The DTG analysis showed ~2.5°C increase (0.94%) in the T max of the Biofield Energy Treated silver sulfadiazine sample compared with the control sample. Thus, the overall data suggests that the Trivedi Effect ® -Consciousness Energy Healing Treatment might generate a novel polymorph of silver sulfadiazine which would be more soluble, absorbable, and bioavailable and thermally more stable compared with the untreated sample. Hence, the Trivedi Effect ® Treated silver sulfadiazine can provide better therapeutic benefits to prevent and treat microbial infections by designing more efficacious pharmaceutical formulations.
